Nearly half of voters support the Republican health-care bill. But it's the ObamaCare holdovers they like.


An entire 46 percent of voters say they approve of the Republican health-care proposal, a Politico/Morning Consult poll released Wednesday has found. "Given the wave of criticism from both parties following the rollout of the bill, this is a relatively strong starting point for GOP leaders and the White House," said Morning Consult's co-founder Kyle Dropp. "However, it will be important to track how public opinion stands up as more information is released in the coming weeks."
More than 35 percent of people said they disapprove of the Affordable Care Act replacement. When asked if the Republican bill will make the health-care system better or worse, 34 percent of voters said better and 33 percent said worse.
Ultimately, when asked to evaluate specific provisions in the bill, the existing Affordable Care Act provisions were more popular than the GOP's new introductions, such as requiring adults to pay a 30 percent penalty if their coverage lapses. On the other hand, 71 percent of voters wanted the ObamaCare replacement to prohibit insurers from denying coverage to patients with pre-existing conditions, and 68 percent of voters thought the bill should allow people under 26 to stay on their parents' plans. Overall, 47 percent of people approve of ObamaCare and 47 percent disapprove.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Politico/Morning Consult poll surveyed 1,983 registered voters between March 9 and 13, entirely before the release of the evaluation of the bill by the Congressional Budget Office. The poll has a margin of error of plus or minus 2 percent. Read the full results of the poll at Politico here.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
July 5 editorial cartoons
Cartoons Saturday’s political cartoons include an extrajudicial detainment camp, 'alligator Alcatraz', and tax cuts for billionaires.
-
5 explosively funny cartoons about the 4th of July
Cartoons Artists take on liberty and justice for all, a terrifying firework, and more
-
Jeff in Venice: a "triumph of tackiness"?
In the Spotlight Locals protest as Bezos uses the city as a 'private amusement park' for his wedding celebrations
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
A disproven medical theory could be guiding RFK Jr.'s health policy
The Explainer The miasma theory is one of the oldest medical beliefs in history
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
Women need more pain management during gynecological procedures
Under the radar Pain should no longer be ignored
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts